In 118 participants with T2DM of the population-based KORA-Age study, during a follow-up of three years, the SMI decline was significantly more marked in patients treated with oral glucose-lowering drugs compared to insulin therapy, suggesting a positive effect of insulin treatment on muscle mass. Here, INS is linked to type 2 diabetes mellitus.